Literature DB >> 534073

Acute therapeutic modalities for experimental vasogenic edema.

R D Harbaugh, H E James, L F Marshall, H M Shapiro, R Laurin.   

Abstract

Experimental vasogenic cerebral edema was created in rabbits with a cold-induced left occipital cortical lesions. Intracranial pressure (ICP), intracranial elastance (Em), water content, hemispheric brain tissue volume, electrolytes, electroencephalograms, behavior, and gross pathology were studied. Various therapeutic modalities were employed alone or in combination to reduce ICP acutely: acetazolamide, furosemide, mannitol, pentobarbital, lorazepam, and dexamethasone. All therapies except dexamethasone were effective in reducing ICP. Peak ICP reduction occurred at 27 +/- 9.8 (SD) minutes with mannitol and at 71.4 +/- 15.5 minutes with acetazolamide, with the remaining agents and combinations falling between these two extreme values. Em improved by 31.7 +/- 17.02% in all therapuetic trials except those employing acetazolamide and lorazepam. With therapy, there was a reduction in the water content of the hemispheres, but the difference from that in the untreated, lesioned animals was not statistically significant. In the lesioned left hemisphere, sodium content was increased by acetazolamide (p less than 0.005), furosemide (p less than 0.025), pentobarbital (p less than 0.05), and the combination of dexamethasone, pentobarbital, and mannitol (p less than 0.005). Significant reduction was noted in the lesioned group for the potassium content of the left hemisphere in the dexamethasone (p less than 0.05), pentobarbital (p less than 0.025), and combination groups containing these agents (p less than 0.005 to 0.025). (Neurosurgery, 5: 656--665, 1979).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 534073     DOI: 10.1227/00006123-197912000-00002

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Intracranial hypertension and brain oedema in albino rabbits. Part 2: Effects of acute therapy with diuretics.

Authors:  C Millson; H E James; H M Shapiro; R Laurin
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

2.  Intracranial hypertension and brain oedema in albino rabbits. Part 3: Effect of acute simultaneous diuretic and barbiturate therapy.

Authors:  C H Millson; H E James; H M Shapiro; R Laurin
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

3.  Modification of the effect of dimethyl sulfoxide on intracranial pressure, brain water, and electrolyte content by indomethacin.

Authors:  H Tung; H E James; R Laurin; L F Marshall
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

4.  Acute dimethyl sulphoxide therapy in experimental brain oedema, effect of dose and concentration on brain water and electrolyte content.

Authors:  J Tsuruda; H E James; R Werner; P E Camp; G Rasmussen
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

5.  Comparison of the effects of DMSO and pentobarbitone on experimental brain oedema.

Authors:  H E James; P E Camp; R D Harbaugh; L F Marshall; R Werner
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

6.  Effect of dexamethasone, barbiturate and hypothermy on edema induced by CO2 laser brain lesion in the dog: light and electron microscopic study.

Authors:  A I Göçer; F Ildan; S Polat; H Bağdatoğlu; N Tunah; M Kaya; S Haciyakupoğlu
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

7.  Intracranial hypertension and brain oedema in albino rabbits. Part I: Experimental models.

Authors:  H E James; R A Laurin
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

Review 8.  Traumatic brain injury and recovery mechanisms: peptide modulation of periventricular neurogenic regions by the choroid plexus-CSF nexus.

Authors:  Conrad Johanson; Edward Stopa; Andrew Baird; Hari Sharma
Journal:  J Neural Transm (Vienna)       Date:  2010-10-10       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.